{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T15:26:41Z","timestamp":1793806001520,"version":"4.6.1"},"reference-count":113,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":958,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Fondo de Investigaci\u00f3n Sanitaria","award":["PI080126"],"award-info":[{"award-number":["PI080126"]}]},{"name":"Fondo de Investigaci\u00f3n Sanitaria","award":["EC\/90077"],"award-info":[{"award-number":["EC\/90077"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.jhep.2010.08.001","type":"journal-article","created":{"date-parts":[[2010,8,14]],"date-time":"2010-08-14T05:02:05Z","timestamp":1281762125000},"page":"1135-1145","source":"Crossref","is-referenced-by-count":101,"title":["Renal and circulatory dysfunction in cirrhosis: Current management and future perspectives"],"prefix":"10.1016","volume":"53","author":[{"given":"Elsa","family":"Sol\u00e0","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pere","family":"Gin\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2010.08.001_b0005","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1136\/jech.2008.086538","article-title":"Trends in socio-economic inequalities in cirrhosis mortality in an urban area of Southern Europe: a multilevel approach","volume":"64","author":"Dalmau-Bueno","year":"2010","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.jhep.2010.08.001_b0010","first-page":"1","article-title":"Deaths: final data for 2006","volume":"57","author":"Heron","year":"2009","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.jhep.2010.08.001_b0015","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1053\/j.gastro.2009.02.038","article-title":"Burden of digestive diseases in the United States. Part III: Liver, biliary tract, and pancreas","volume":"136","author":"Everhart","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.08.001_b0020","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0140-6736(08)60383-9","article-title":"Liver cirrhosis","volume":"371","author":"Schuppan","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2010.08.001_b0025","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1034\/j.1600-0676.2002.00001.x","article-title":"The pathophysiological basis of acute-on-chronic liver failure","volume":"22","author":"Sen","year":"2002","journal-title":"Liver"},{"key":"10.1016\/j.jhep.2010.08.001_b0030","series-title":"Diseases of the kidney and urinary tract","first-page":"2179","article-title":"Liver disease and the kidney","author":"Gin\u00e8s","year":"2007"},{"key":"10.1016\/j.jhep.2010.08.001_b0035","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.1840080532","article-title":"Peripheral arterial vasodilatation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis","volume":"8","author":"Schrier","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.08.001_b0040","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/hep.510230122","article-title":"Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis","volume":"23","author":"Arroyo","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.08.001_b0045","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJM199808203390807","article-title":"Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis","volume":"339","author":"Martin","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2010.08.001_b0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-2008-1040318","article-title":"Portal hypertension and gastrointestinal bleeding","volume":"28","author":"Bosch","year":"2008","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2010.08.001_b0055","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1002\/hep.20993","article-title":"The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule","volume":"43","author":"Iwakiri","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.08.001_b0060","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1053\/gast.2002.30305","article-title":"Endogenous cannabinoids: a new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat","volume":"122","author":"Ros","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.08.001_b0065","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1042\/cs0890183","article-title":"Vascular and hormonal responses to arginine: provision of substrate for nitric oxide or non-specific effect?","volume":"89","author":"MacAllister","year":"1995","journal-title":"Clin Sci"},{"key":"10.1016\/j.jhep.2010.08.001_b0070","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/hep.20766","article-title":"Circulatory function and hepatorenal syndrome in cirrhosis","volume":"42","author":"Ruiz-del-Arbol","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.08.001_b0075","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/hep.21940","article-title":"Lack of renal improvement with nonselective endothelin antagonism with tezosentan in type 2 hepatorenal syndrome","volume":"47","author":"Wong","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.08.001_b0080","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/gut.2009.180570","article-title":"Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites","volume":"59","author":"Krag","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2010.08.001_b0085","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jhep.2010.02.023","article-title":"Cirrhotic cardiomyopathy","volume":"53","author":"Moller","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.08.001_b0090","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1172\/JCI7458","article-title":"Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility","volume":"104","author":"Wiest","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2010.08.001_b0095","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/hep.20632","article-title":"Bacterial translocation (BT) in cirrhosis","volume":"41","author":"Wiest","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.08.001_b0100","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1053\/jhep.2003.50038","article-title":"Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement","volume":"37","author":"Albillos","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.08.001_b0105","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/hep.22083","article-title":"Bacterial DNA in patients with cirrhosis and noninfected ascites mimics the soluble immune response established in patients with spontaneous bacterial peritonitis","volume":"47","author":"Franc\u00e9s","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.08.001_b0110","doi-asserted-by":"crossref","first-page":"985","DOI":"10.7326\/0003-4819-127-11-199712010-00007","article-title":"Effect of fluoroquinolone on the enhanced nitric oxide-induced peripheral vasodilation seen in cirrhosis","volume":"127","author":"Chin-Dusting","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2010.08.001_b0115","doi-asserted-by":"crossref","first-page":"186","DOI":"10.7326\/0003-4819-139-3-200308050-00008","article-title":"The effect of selective intestinal decontamination on the hyperdynamic circulatory state in cirrhosis: a randomized trial","volume":"139","author":"Rasaratnam","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2010.08.001_b0120","doi-asserted-by":"crossref","first-page":"155","DOI":"10.7326\/0003-4819-113-2-155","article-title":"Body fluid volume regulation in health and disease: a unifying hypothesis","volume":"113","author":"Schrier","year":"1990","journal-title":"Ann Int Med"},{"key":"10.1016\/j.jhep.2010.08.001_b0125","series-title":"Ascites and renal dysfunction in liver diseases","first-page":"3","article-title":"Extracellular fluid volume homeostasis","author":"Poole","year":"2005"},{"key":"10.1016\/j.jhep.2010.08.001_b0130","series-title":"Ascites and renal dysfunction in liver diseases","first-page":"201","article-title":"Pathogenesis of sodium retention in cirrhosis: the arterial vasodilation hypothesis of ascites formation","author":"Fernandez de la Llama","year":"2005"},{"key":"10.1016\/j.jhep.2010.08.001_b0135","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/qjmed\/hcm121","article-title":"Fluid retention in cirrhosis: pathophysiology and management","volume":"101","author":"Kashani","year":"2008","journal-title":"QJM"},{"key":"10.1016\/j.jhep.2010.08.001_b0140","doi-asserted-by":"crossref","unstructured":"EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome in cirrosis. J Hepatol 2010;53:397\u2013417.","DOI":"10.1016\/j.jhep.2010.05.004"},{"key":"10.1016\/j.jhep.2010.08.001_b0145","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/0016-5085(83)90198-1","article-title":"Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the renin\u2013aldosterone system","volume":"84","author":"P\u00e9rez-Ayuso","year":"1983","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.08.001_b0150","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1002\/hep.22853","article-title":"AASLD Practice Guidelines Committee. Management of adult patients with ascites due to cirrhosis: an update","volume":"49","author":"Runyon","year":"2009","journal-title":"Hepatology"},{"issue":"Suppl. 6","key":"10.1016\/j.jhep.2010.08.001_b0155","first-page":"vi1","article-title":"Guidelines on the management of ascites in cirrhosis","volume":"55","author":"Moore","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2010.08.001_b0160","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1038\/ajg.2009.191","volume":"104","author":"Garcia-Tsao","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2010.08.001_b0165","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/0016-5085(87)91007-9","article-title":"Comparison of paracentesis and diuretics in the management of tense ascites. Results of a randomized, study","volume":"93","author":"Gin\u00e8s","year":"1987","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.08.001_b0170","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/0016-5085(88)90691-9","article-title":"Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis","volume":"94","author":"Gin\u00e8s","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.08.001_b0175","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1053\/gast.2002.37073","article-title":"Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis","volume":"123","author":"Gin\u00e8s","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.08.001_b0180","first-page":"797","article-title":"Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites","volume":"128","author":"Salerno","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.08.001_b0185","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1053\/j.gastro.2005.07.031","article-title":"Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis","volume":"129","author":"D\u2019Amico","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.08.001_b0190","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.jhep.2005.06.005","article-title":"A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites","volume":"43","author":"Albillos","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.08.001_b0195","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1053\/jhep.2003.50133","article-title":"Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis in cirrhosis","volume":"37","author":"Abraldes","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.08.001_b0200","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1053\/j.gastro.2009.03.048","article-title":"Acute hemodynamic response to \u03b2-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding","volume":"137","author":"Villanueva","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.08.001_b0205","doi-asserted-by":"crossref","unstructured":"Serst\u00e9 T, Melot C, Francoz C, Durand F, Rautou PE, Valla D, et al. Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites. Hepatology 2010 in press.","DOI":"10.1002\/hep.23775"},{"key":"10.1016\/j.jhep.2010.08.001_b0210","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/hep.21355","article-title":"Effects of clonidine on diuretic response in ascitic patients with cirrhosis and activation of sympathetic nervous system","volume":"44","author":"Lenaerts","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.08.001_b0215","doi-asserted-by":"crossref","first-page":"F1267","DOI":"10.1152\/ajprenal.00069.2003","article-title":"Effects of sympathetic nerves and angiotensin II on renal sodium and water handling in rats with common bile duct ligature","volume":"288","author":"Veelken","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.jhep.2010.08.001_b0220","doi-asserted-by":"crossref","first-page":"446","DOI":"10.7326\/0003-4819-116-6-446","article-title":"Increased sympathetic nervous activity and the effects of its inhibition with clonidine in alcoholic cirrhosis","volume":"116","author":"Esler","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2010.08.001_b0225","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/hep.510280407","article-title":"Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites","volume":"28","author":"Angeli","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.08.001_b0230","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jhep.2006.09.012","article-title":"Effects of a 7-day treatment with midodrine in non-azotemic cirrhotic patients with and without ascites","volume":"46","author":"Kalambokis","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.08.001_b0235","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jhep.2004.05.009","article-title":"Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"41","author":"Fern\u00e1ndez","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.08.001_b0240","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.3748\/wjg.v12.i9.1403","article-title":"Long-term albumin infusion improves survival in patients with cirrhosis and ascites: an unblinded randomized trial","volume":"12","author":"Romanelli","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2010.08.001_b0245","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/0016-5085(93)90655-V","article-title":"Role of nitric oxide in the in vitro splanchnic vascular hyporeactivity in ascitic cirrhotic rats","volume":"104","author":"Sieber","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.08.001_b0250","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1172\/JCI626","article-title":"Nitric oxide synthase (NOS) inhibition for one week improves renal sodium and water excretion in cirrhotic rats with ascites","volume":"101","author":"Martin","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2010.08.001_b0255","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/01.CCM.0000105581.01815.C6","article-title":"Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock","volume":"32","author":"L\u00f3pez","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jhep.2010.08.001_b0260","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1053\/jhep.2002.31432","article-title":"The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough","volume":"35","author":"Wiest","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.08.001_b0265","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jhep.2003.09.018","article-title":"A liver-specific nitric oxide donor improves the intra-hepatic vascular response to both portal blood flow increase and methoxamine in cirrhotic rats","volume":"39","author":"Loureiro-Silva","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.08.001_b0270","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ajg.2009.661","article-title":"NCX-1000, a nitric oxide-releasing derivative of UDCA, does not decrease portal pressure in patients with cirrhosis: results of a randomized, double-blind, dose-escalating study","volume":"105","author":"Berzigotti","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2010.08.001_b0275","doi-asserted-by":"crossref","first-page":"G14","DOI":"10.1152\/ajpgi.2001.280.1.G14","article-title":"Systemic and portal hemodynamic effects of anandamide","volume":"280","author":"Garcia","year":"2001","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2010.08.001_b0280","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/89953","article-title":"Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis","volume":"7","author":"B\u00e1tkais","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2010.08.001_b0285","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1053\/j.gastro.2009.01.004","article-title":"Cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis","volume":"137","author":"Domenicali","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.08.001_b0290","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/S0140-6736(08)60695-9","article-title":"Non-peptide arginine\u2013vasopressin antagonists: the vaptans","volume":"371","author":"Decaux","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2010.08.001_b0295","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/hep.22293","article-title":"Effects of satavaptan, a selective vasopressin V(2) receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: a randomized trial","volume":"48","author":"Gin\u00e8s","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.08.001_b0300","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/j.1365-2036.2010.04236.x","article-title":"Clinical trial: short-term effects of combination of satavaptan, a selective vasopressin V2 receptor antagonist, and diuretics on ascites in patients with cirrhosis without hyponatremia \u2013 a randomized, double-blind, placebo-controlled study","volume":"31","author":"Gin\u00e8s","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2010.08.001_b0305","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jhep.2010.02.036","article-title":"Effects of a selective vasopressin V2 receptor antagonist, satavaptan, on ascites recurrence after paracentesis in patients with cirrhosis","volume":"53","author":"Wong","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.08.001_b0310","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/S0168-8278(09)60104-5","article-title":"Effects of satavaptan, an oral vasopressin V2 receptor antagonist, on management of ascites and morbidity in liver cirrosis in a long-term, placebo-controlled study","volume":"50","author":"Wong","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.08.001_b0315","first-page":"448A","article-title":"Double-blind, placebo-controlled study of satavaptan in the management of recurrent ascites: the SPARE-1 study","volume":"50S","author":"Wong","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.08.001_b0320","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/hep.22418","article-title":"Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management","volume":"48","author":"Gin\u00e8s","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.08.001_b0325","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/BF01095898","article-title":"Prognostic value of spontaneous hyponatremia in cirrhosis with ascites","volume":"21","author":"Arroyo","year":"1976","journal-title":"Am J Dig Dis"},{"key":"10.1016\/j.jhep.2010.08.001_b0330","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1038\/ajg.2009.293","article-title":"Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis","volume":"104","author":"Guevara","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2010.08.001_b0335","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1136\/gut.2007.122176","article-title":"Pathogenetic mechanisms of hepatic encephalopathy","volume":"57","author":"H\u00e4ussinger","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2010.08.001_b0340","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/lt.21154","article-title":"The impact of serum sodium concentration on mortality after liver transplantation: a cohort multicenter study","volume":"13","author":"Dawwas","year":"2007","journal-title":"Liver transpl"},{"key":"10.1016\/j.jhep.2010.08.001_b0345","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/hep.1840400409","article-title":"Persistent ascites and low serum sodium identify patients at high risk for early death","volume":"40","author":"Heuman","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.08.001_b0350","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.20517","article-title":"Serum sodium predicts mortality in patients listed for liver transplantation","volume":"41","author":"Biggins","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.08.001_b0355","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMoa0801209","article-title":"Hyponatremia and mortality among patients on the liver transplantation waiting list","volume":"359","author":"Kim","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2010.08.001_b0360","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000183112","article-title":"Effect of demeclocycline on renal function and urinary prostaglandin E2 and kallikrein in hyponatremic cirrhotics","volume":"36","author":"P\u00e9rez-Ayuso","year":"1984","journal-title":"Nephron"},{"key":"10.1016\/j.jhep.2010.08.001_b0365","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0168-8278(00)80187-7","article-title":"Aquaretic effects of niravoline, a kappa-opioid agonist, in patients with cirrhosis","volume":"32","author":"Gadano","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.08.001_b0370","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1002\/lt.21836","article-title":"Conivaptan increases serum sodium in hyponatremic patients with end-stage liver disease","volume":"15","author":"O\u2019Leary","year":"2009","journal-title":"Liver transpl"},{"key":"10.1016\/j.jhep.2010.08.001_b0375","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1056\/NEJMoa065181","article-title":"Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia","volume":"355","author":"Schrier","year":"2006","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jhep.2010.08.001_b0380","first-page":"467A","article-title":"The effects of a vasopressin V2 receptor antagonist in the management of patients with cirrhosis and hyponatremia. Safety and efficacy of oral tolvaptan in the SALT trials","volume":"50S","author":"Cardenas","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.08.001_b0385","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1053\/j.gastro.2006.02.017","article-title":"Hyponatremia impairs early posttransplantation outcome in patients with cirrhosis undergoing liver transplantation","volume":"130","author":"Londo\u00f1o","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.08.001_b0390","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/gut.31.2.204","article-title":"Intravenous albumin infusion is an effective therapy for hyponatremia in cirrhotic patients with ascites","volume":"31","author":"McCormick","year":"1990","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2010.08.001_b0395","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1016\/S0168-8278(07)61830-3","article-title":"Albumin infusion for severe hyponatremia in patients with refractory ascites: a randomized clinical trial","volume":"46","author":"Jalan","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.08.001_b0400","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(03)14903-3","article-title":"Hepatorenal syndrome","volume":"362","author":"Gin\u00e8s","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2010.08.001_b0405","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMra0809139","article-title":"Renal failure in cirrhosis","volume":"361","author":"Gin\u00e8s","year":"2009","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jhep.2010.08.001_b0410","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/hep.23286","article-title":"Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome","volume":"51","author":"Gluud","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.08.001_b0415","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1053\/j.gastro.2008.02.014","article-title":"A randomized, prospective, double-blind, placebo-controlled trial of terlipressina for type 1 hepatorenal syndrome","volume":"134","author":"Sanyal","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.08.001_b0420","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/gut.49.5.729","article-title":"The hepatorenal syndrome","volume":"49","author":"Dagher","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2010.08.001_b0425","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/j.jhep.2008.01.010","article-title":"Pathogenesis and management of hepatorenal syndrome in patients with cirrhosis","volume":"48","author":"Angeli","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.08.001_b0430","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/hep.20687","article-title":"MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation","volume":"41","author":"Alessandria","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.08.001_b0435","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/hep.21094","article-title":"The use of vasoconstrictors in patients with cirrhosis: type 1 HRS and beyond","volume":"43","author":"Moreau","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.08.001_b0440","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/hep.22097","article-title":"Therapy with vasoconstrictor drugs in cirrhosis: the time has arrived","volume":"46","author":"Gin\u00e8s","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.08.001_b0445","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/hep.23283","article-title":"Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome","volume":"51","author":"Nazar","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.08.001_b0450","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1053\/jhep.2002.35819","article-title":"Terlipressin therapy with and without alb\u00famina for patients with hepatorenal syndrome: results of a prospective, nonrandomized study","volume":"36","author":"Ortega","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.08.001_b0455","first-page":"401","article-title":"Renal Failure in cirrhotic patients: role of terlipressin in clinical approach to hepatorenal syndrome type 2","volume":"47","author":"Alessandria","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2010.08.001_b0460","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1053\/j.gastro.2008.02.024","article-title":"Terlipressin and alb\u00famina vs alb\u00famina in patients with cirrhosis and hepatorenal syndrome: a randomized study","volume":"134","author":"Martin LLahi","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.08.001_b0465","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/hep.510290629","article-title":"Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide","volume":"29","author":"Angeli","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.08.001_b0470","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/hep.20262","article-title":"Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome","volume":"40","author":"Wong","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.08.001_b0475","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1053\/jhep.2002.34343","article-title":"Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study","volume":"36","author":"Duvoux","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.08.001_b0480","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/hep.510280219","article-title":"Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems","volume":"28","author":"Guevara","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.08.001_b0485","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/ACO.0b013e32833724a8","article-title":"Renal failure in patients with cirrhosis: hepatorenal syndrome and renal support strategies","volume":"23","author":"Meltzer","year":"2010","journal-title":"Curr Opin Anaesthesiol"},{"key":"10.1016\/j.jhep.2010.08.001_b0490","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1592\/phco.29.10.1196","article-title":"Treatment of hepatorenal syndrome","volume":"29","author":"Kiser","year":"2009","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jhep.2010.08.001_b0495","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1002\/lt.21877","article-title":"International Liver Transplantation Society Expert Panel. Report of the first international liver transplantation society expert panel consensus conference on renal insufficiency in liver transplantation","volume":"15","author":"Charlton","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2010.08.001_b0500","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","article-title":"Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"341","author":"Sort","year":"1999","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jhep.2010.08.001_b0505","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1053\/gast.2000.20189","article-title":"Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial","volume":"119","author":"Akriviadis","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.08.001_b0510","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1053\/j.gastro.2010.01.040","article-title":"Pentoxifylline does not decrease short term mortality but does reduce complications in patients with advanced cirrhosis","volume":"138","author":"Lebrec","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.08.001_b0515","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1053\/j.gastro.2007.06.065","article-title":"Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis","volume":"133","author":"Fern\u00e1ndez","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.08.001_b0520","first-page":"94A","article-title":"Terlipressin given as continuous intravenous infusion is the more suitable schedule for the treatment of type 1 hepatorenal syndrome (HRS) in patients with cirrhosis: results of a controlled clinical study","volume":"48","author":"Angeli","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.08.001_b0525","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1007\/s00134-007-0676-1","article-title":"Continuous terlipressin infusion in patients with septic shock: less may be best, and the earlier the better?","volume":"33","author":"Morelli","year":"2007","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jhep.2010.08.001_b0530","first-page":"59","article-title":"Effect of dypiridamole on kidney function in cirrhosis","volume":"17","author":"Llach","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.08.001_b0535","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0016-5085(98)70207-0","article-title":"Natriuretic effect of an adenosine-1 receptor antagonist in cirrhotic patients with ascites","volume":"115","author":"Stanley","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.08.001_b0540","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0168-8278(10)60008-6","article-title":"Extracorporeal liver support by fractionated plasma separation and adsorption (Prometheus\u00ae) in patients with acute-on-chronic liver failure (HELIOS Study): a prospective randomized controlled multicenter study","volume":"52","author":"Rifai","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.08.001_b0545","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1053\/lv.2000.6355","article-title":"Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial","volume":"6","author":"Mitzner","year":"2000","journal-title":"Liver transpl"},{"key":"10.1016\/j.jhep.2010.08.001_b0550","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1046\/j.1526-0968.2001.00388.x","article-title":"Improvement of multiple organ functions in hepatorenal syndrome during albumin dialysis with the molecular adsorbent recirculating system","volume":"5","author":"Mitzner","year":"2001","journal-title":"Ther Apher"},{"key":"10.1016\/j.jhep.2010.08.001_b0555","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1002\/hep.22325","article-title":"Molecular adsorbents recirculating system (MARS) and the failing liver: a negative editorial for a positive trial?","volume":"47","author":"Arroyo","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.08.001_b0560","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.3748\/wjg.14.2065","article-title":"Effect of Prometheus liver assist system on systemic hemodynamics in patients with cirrhosis: a randomized controlled study","volume":"14","author":"Dethloff","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2010.08.001_b0565","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1365-2036.2007.03420.x","article-title":"Acute systemic, splanchnic and renal haemodynamic changes induced by molecular adsorbent recirculating system (MARS) treatment in patients with end-stage cirrhosis","volume":"26","author":"Donati","year":"2007","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827810006987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827810006987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T10:25:28Z","timestamp":1711707928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827810006987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":113,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0168827810006987"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2010.08.001","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}